As I've stated at each of our earnings calls this year, we continue to pursue and find further incremental operating efficiencies. The GAAP net loss for Q3 2024 was approximately $14.9 million, ...
Performance in Q3 was very strong for the Group and once again ahead of market expectations ... Our third quarter diluted loss per share and adjusted earnings per share improved year-over-year however ...
Q3 average monthly paying clients of 5,100 marked another consecutive quarterly increase ... A reconciliation of non-GAAP metrics to their nearest GAAP result, as well as the details of our share ...
CAMBRIDGE, Britain — CAMBRIDGE, Britain — Astrazeneca PLC (AZN) on Tuesday reported third-quarter earnings of $1.43 billion. On a per-share basis, the Cambridge, Britain-based company said it had ...
BOCA RATON, Fla. — BOCA RATON, Fla. — TherapeuticsMD Inc. (TXMD) on Tuesday reported a loss of $609,000 in its third quarter. The Boca Raton, Florida-based company said it had a loss of 5 cents per ...